CIBC Private Wealth Group, LLC - LION BIOTECHNOLOGIES INC ownership

LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 85 filers reported holding LION BIOTECHNOLOGIES INC in Q4 2015. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
CIBC Private Wealth Group, LLC ownership history of LION BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2017$320,000
+7.0%
43,0000.0%0.00%0.0%
Q4 2016$299,000
-15.5%
43,0000.0%0.00%0.0%
Q3 2016$354,000
+1.7%
43,0000.0%0.00%
-33.3%
Q2 2016$348,000
+59.6%
43,0000.0%0.00%
+50.0%
Q1 2016$218,000
-34.3%
43,0000.0%0.00%
-33.3%
Q4 2015$332,000
+33.9%
43,0000.0%0.00%
+50.0%
Q3 2015$248,000
-37.1%
43,0000.0%0.00%
-33.3%
Q2 2015$394,000
-24.4%
43,0000.0%0.00%
-25.0%
Q1 2015$521,00043,0000.00%
Other shareholders
LION BIOTECHNOLOGIES INC shareholders Q4 2015
NameSharesValueWeighting ↓
Ayer Capital Management, LP 2,823,333$25,890,00096.51%
Avoro Capital Advisors LLC 2,923,065$26,805,0007.38%
ACUTA CAPITAL PARTNERS, LLC 886,000$8,125,0005.02%
Perceptive Advisors 2,759,593$25,305,0001.52%
Ghost Tree Capital, LLC 350,000$3,210,0001.04%
Broadfin Capital, LLC 1,812,419$16,620,0000.89%
P.A.W. CAPITAL CORP 80,000$734,0000.74%
Rhenman & Partners Asset Management AB 556,000$5,099,0000.61%
Cormorant Asset Management, LP 499,815$4,583,0000.61%
Trellus Management Company, LLC 38,500$353,0000.40%
View complete list of LION BIOTECHNOLOGIES INC shareholders